The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B
Open Access
- 28 February 2005
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (2) , 158-162
- https://doi.org/10.1016/j.jhep.2004.12.001
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonrespondersJournal of Hepatology, 2003
- Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis BHepatology, 2002
- Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis BLiver Transplantation, 2002
- Lamivudine Treatment Is Beneficial in Patients With Severely Decompensated Cirrhosis and Actively Replicating Hepatitis B Infection Awaiting Liver Transplantation: A Comparative Study Using A Matched, Untreated CohortHepatology, 2001
- Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infectionJournal of Hepatology, 2000
- Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trialGut, 2000
- Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis BHepatology, 2000
- Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver TransplantationHepatology, 1999
- Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis BbHepatology, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998